Disruption of pathways regulated by Integrator complex in Galloway-Mowat syndrome due to WDR73 mutations.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
08 03 2021
Historique:
received: 05 05 2020
accepted: 11 02 2021
entrez: 9 3 2021
pubmed: 10 3 2021
medline: 15 12 2021
Statut: epublish

Résumé

Several studies have reported WDR73 mutations to be causative of Galloway-Mowat syndrome, a rare disorder characterised by the association of neurological defects and renal-glomerular disease. In this study, we demonstrate interaction of WDR73 with the INTS9 and INTS11 components of Integrator, a large multiprotein complex with various roles in RNA metabolism and transcriptional control. We implicate WDR73 in two Integrator-regulated cellular pathways; namely, the processing of uridylate-rich small nuclear RNAs (UsnRNA), and mediating the transcriptional response to epidermal growth factor stimulation. We also show that WDR73 suppression leads to altered expression of genes encoding cell cycle regulatory proteins. Altogether, our results suggest that a range of cellular pathways are perturbed by WDR73 loss-of-function, and support the consensus that proper regulation of UsnRNA maturation, transcription initiation and cell cycle control are all critical in maintaining the health of post-mitotic cells such as glomerular podocytes and neurons, and preventing degenerative disease.

Identifiants

pubmed: 33686175
doi: 10.1038/s41598-021-84472-7
pii: 10.1038/s41598-021-84472-7
pmc: PMC7940485
doi:

Substances chimiques

Proteins 0
WDR73 protein, human 0
Endoribonucleases EC 3.1.-
IntS9 protein, human EC 3.1.-
INTS11 protein, human EC 3.1.27

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5388

Références

Seizure. 2010 Mar;19(2):132-5
pubmed: 20083416
J Am Soc Nephrol. 2015 May;26(5):1115-25
pubmed: 25185988
J Clin Invest. 2018 Aug 31;128(9):4132-4147
pubmed: 29990311
Genes Dev. 2017 Sep 1;31(17):1809-1820
pubmed: 28982763
Oncogene. 2003 Jan 16;22(2):211-9
pubmed: 12527890
Nat Genet. 2017 Oct;49(10):1529-1538
pubmed: 28805828
Nat Rev Mol Cell Biol. 2014 Feb;15(2):108-21
pubmed: 24452469
Am J Med Genet A. 2012 Mar;158A(3):606-10
pubmed: 22302400
Cell. 2000 Jan 7;100(1):57-70
pubmed: 10647931
Mol Cell Biol. 2012 Mar;32(6):1112-23
pubmed: 22252320
J Med Genet. 1968 Dec;5(4):319-21
pubmed: 5713646
Kidney Int. 2010 Nov;78(9):868-82
pubmed: 20664558
Am J Med Genet A. 2018 Nov;176(11):2460-2465
pubmed: 30079490
Science. 2011 Apr 8;332(6026):238-40
pubmed: 21474760
Kidney Int. 2006 Aug;70(3):529-35
pubmed: 16775597
Trends Genet. 2019 Feb;35(2):104-117
pubmed: 30563726
Am J Physiol Renal Physiol. 2018 Jan 1;314(1):F22-F34
pubmed: 28877882
Am J Med Genet A. 2016 Apr;170A(4):992-8
pubmed: 27001912
Clin Chim Acta. 2017 Jan;464:24-29
pubmed: 27983999
Proc Natl Acad Sci U S A. 2017 Apr 25;114(17):4394-4399
pubmed: 28396433
Am J Pathol. 2013 Jul;183(1):3-9
pubmed: 23790801
Methods Mol Biol. 2016;1342:71-88
pubmed: 26254918
J Cell Biol. 1998 Apr 20;141(2):503-14
pubmed: 9548727
Eur J Med Genet. 2019 Sep;62(9):103550
pubmed: 30315938
J Am Soc Nephrol. 2002 Mar;13(3):630-8
pubmed: 11856766
Kidney Int. 2007 Jun;71(12):1205-14
pubmed: 17410103
Cell Cycle. 2016 Jul 17;15(14):1929-37
pubmed: 27232327
Am J Pathol. 2013 Nov;183(5):1364-1374
pubmed: 24007883
Genomics. 2009 Aug;94(2):83-8
pubmed: 19446021
PLoS Genet. 2017 May 25;13(5):e1006809
pubmed: 28542170
J Med Genet. 2015 Jun;52(6):381-90
pubmed: 25873735
Brain. 2015 Aug;138(Pt 8):2173-90
pubmed: 26070982
Mol Cell. 2014 Oct 2;56(1):128-139
pubmed: 25201415
Nat Rev Mol Cell Biol. 2010 May;11(5):353-65
pubmed: 20414257
Am J Kidney Dis. 2003 Jun;41(6):1179-88
pubmed: 12776269
Curr Mol Med. 2013 Jan;13(1):13-23
pubmed: 23176147
Nat Rev Mol Cell Biol. 2012 Sep;13(9):543-7
pubmed: 22895430
Cell. 2005 Oct 21;123(2):265-76
pubmed: 16239144
Trends Biochem Sci. 2015 May;40(5):257-64
pubmed: 25882383
Nat Rev Cancer. 2011 Jul 07;11(8):558-72
pubmed: 21734724
Oncogene. 2000 Nov 20;19(49):5558-67
pubmed: 11114735
Nat Commun. 2019 Sep 3;10(1):3967
pubmed: 31481669
Hum Mutat. 2015 Nov;36(11):1021-8
pubmed: 26123727
Kidney Int. 2006 Jun;69(12):2131-47
pubmed: 16688120
Nucleic Acids Res. 2018 May 4;46(8):4241-4255
pubmed: 29471365
Am J Hum Genet. 2014 Dec 4;95(6):637-48
pubmed: 25466283
Nat Rev Cancer. 2009 Jun;9(6):400-14
pubmed: 19440234

Auteurs

F C Tilley (FC)

Laboratory of Hereditary Kidney Diseases, Imagine Institute, INSERM UMR 1163, Université de Paris, 75015, Paris, France.

C Arrondel (C)

Laboratory of Hereditary Kidney Diseases, Imagine Institute, INSERM UMR 1163, Université de Paris, 75015, Paris, France.

C Chhuon (C)

Proteomics Platform 3P5-Necker, Structure Fédérative de Recherche Necker, INSERM US24/CNRS UMS 3633, Université de Paris, 75015, Paris, France.

M Boisson (M)

Laboratory of Hereditary Kidney Diseases, Imagine Institute, INSERM UMR 1163, Université de Paris, 75015, Paris, France.

N Cagnard (N)

Bioinformatic Core Facility, Structure Fédérative de Recherche Necker, INSERM US24/CNRS UMS 3633, Imagine Institute, Université de Paris, 75015, Paris, France.

M Parisot (M)

Genomics Core Facility, Imagine Institute, Structure Fédérative de Recherche Necker, INSERM U1163 and INSERM US24/CNRS UMS3633, Université de Paris, 75015, Paris, France.

G Menara (G)

Laboratory of Hereditary Kidney Diseases, Imagine Institute, INSERM UMR 1163, Université de Paris, 75015, Paris, France.

N Lefort (N)

iPSC Core Facility, Imagine Institute, INSERM UMR 1163, Université de Paris, 75015, Paris, France.

I C Guerrera (IC)

Proteomics Platform 3P5-Necker, Structure Fédérative de Recherche Necker, INSERM US24/CNRS UMS 3633, Université de Paris, 75015, Paris, France.

C Bole-Feysot (C)

Genomics Core Facility, Imagine Institute, Structure Fédérative de Recherche Necker, INSERM U1163 and INSERM US24/CNRS UMS3633, Université de Paris, 75015, Paris, France.

A Benmerah (A)

Laboratory of Hereditary Kidney Diseases, Imagine Institute, INSERM UMR 1163, Université de Paris, 75015, Paris, France.

C Antignac (C)

Laboratory of Hereditary Kidney Diseases, Imagine Institute, INSERM UMR 1163, Université de Paris, 75015, Paris, France.
Département de Génétique, AP-HP, Hôpital Necker-Enfants Malades, 75015, Paris, France.

G Mollet (G)

Laboratory of Hereditary Kidney Diseases, Imagine Institute, INSERM UMR 1163, Université de Paris, 75015, Paris, France. geraldine.mollet@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH